Yasmin Panjwani
Psychiatric/Mental Health · Crystal River, FLNPI 1194266080
Payments from drug & device makers
Across 81 payments — averaging $23.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$228
- AbbVie$194
- Neurocrine Biosciences, Inc.$155
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$148
- Teva Pharmaceuticals USA, Inc.$140
- Alkermes, Inc.$139
- plus $885 from 17 others
What the payments were for
- Food & beverage$1,889100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 10 | $228 |
| AbbVie | 7 | $194 |
| Neurocrine Biosciences, Inc. | 3 | $155 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $148 |
| Teva Pharmaceuticals USA, Inc. | 7 | $140 |
| Alkermes, Inc. | 3 | $139 |
| Amarin Pharma, Inc. | 6 | $123 |
| Otsuka America Pharmaceutical, Inc. | 2 | $118 |
| Indivior Inc. | 5 | $113 |
| AstraZeneca | 7 | $104 |
| Avanir Pharmaceuticals, Inc. | 4 | $77 |
| Exact Sciences | 3 | $62 |
| Johnson & Johnson | 3 | $57 |
| Astellas Pharma US Inc | 2 | $47 |
| GSK | 3 | $40 |
| Lilly USA, LLC | 1 | $22 |
| Eisai Inc. | 1 | $20 |
| Mylan Specialty L.p. | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Novartis | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Atland Pharmaceuticals, LLC | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$400
- INGREZZA$123
- VRAYLAR$116
- ARISTADA INITIO$100
How this compares
$1,889 in reported general payments places this provider in the 70th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 11 | $309 |
| Sertraline Hcl | 19 | $267 |
| Buspirone Hcl | 13 | $128 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Crystal River
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Kelli BridgmanNew Smyrna Beach$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.